tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
IMAB is currently covered by 4 analysts with an average price target of $13.1. This is a potential upside of $10.53 (409.73%) from yesterday's end of day stock price of $2.57.
I-Mab's activity chart (see below) currently has 16 price targets and 32 ratings on display. The stock rating distribution of IMAB is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 34% with an average time for these price targets to be met of 77.4 days.
Highest price target for IMAB is $7, Lowest price target is $5, average price target is $5.67.
Most recent stock forecast was given by GIL BLUM from NEEDHAM on 27-Jun-2025. First documented stock forecast 11-Feb-2020.
Currently out of the existing stock ratings of IMAB, 15 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$5
$2.43 (94.55%)
$4
2 days ago
(27-Jun-2025)
0/6 (0%)
$2.43 (94.55%)
Buy
$7
$4.43 (172.37%)
2 months 25 days ago
(04-Apr-2025)
1/5 (20%)
$6.32 (929.41%)
85
Buy
$5
$2.43 (94.55%)
$16
1 years 4 months 17 days ago
(12-Feb-2024)
1/2 (50%)
$3.2 (177.78%)
78
Buy
1 years 9 months 24 days ago
(05-Sep-2023)
3/4 (75%)
$13.97 (18.37%)
133
Buy
$35
2 years 2 months 26 days ago
(03-Apr-2023)
1/4 (25%)
$26.73 (323.22%)
91
What is IMAB (I-Mab) average time for price targets to be met?
Which analyst has the current highest performing score on IMAB (I-Mab) with a proven track record?
Which analyst has the current lower performing score on IMAB (I-Mab) with a proven track record?
Which analyst has the most public recommendations on IMAB (I-Mab)?
Which analyst is the currently most bullish on IMAB (I-Mab)?
Which analyst is the currently most reserved on IMAB (I-Mab)?
